Grey Wolf Health (TSXV:WOLF) Shares Outstanding (EOP): 34.49 Mil (As of Mar. 2026)


TSXV:WOLF Grey Wolf Health Corp TSXV:WOLF
52 GF Score
Price C$1.75
GF Value C$1.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Health Shares Outstanding (EOP)?

Grey Wolf Health TSXV:WOLF 52 Shares Outstanding (EOP) is 34.49 Mil as of Mar. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 52/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Grey Wolf Health's shares outstanding for the quarter that ended in Mar. 2026 was 34.49 Mil.

Grey Wolf Health's quarterly shares outstanding increased from Dec. 2025 (34.19 Mil) to Mar. 2026 (34.49 Mil). It means Grey Wolf Health issued new shares from Dec. 2025 to Mar. 2026 .

Grey Wolf Health's annual shares outstanding stayed the same from Dec. 2024 (34.19 Mil) to Dec. 2025 (34.19 Mil).


Grey Wolf Health  (TSXV:WOLF) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Grey Wolf Health Shares Outstanding (EOP) Related Terms


Grey Wolf Health Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Grey Wolf Health's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health Shares Outstanding (EOP) Chart

Grey Wolf Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
31.03 31.03 31.03 34.19 34.19

Grey Wolf Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.19 34.19 34.19 34.19 34.49

TSXV:WOLF vs ROL, SCI, FTDR: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grey Wolf Health's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grey Wolf Health Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grey Wolf Health's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Grey Wolf Health's Shares Outstanding (EOP) falls into.


TSXV:WOLF
52GF Score
Grey Wolf Health Corp TSXV:WOLF
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Wolf Health Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 34.49 Mil mean?
Grey Wolf Health (TSXV:WOLF) has a Shares Outstanding (EOP) of 34.49 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Grey Wolf Health and its competitors.
Is Grey Wolf Health's Shares Outstanding (EOP) too high?
Grey Wolf Health's current Shares Outstanding (EOP) is 34.49 Mil. Overall, Grey Wolf Health has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's Shares Outstanding (EOP) compare to ROL and SCI?
Grey Wolf Health's Shares Outstanding (EOP) of 34.49 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Grey Wolf Health and its competitors. Grey Wolf Health's current Shares Outstanding (EOP) is 34.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.75 — trading 59.1% above its estimated fair value. The current Shares Outstanding (EOP) is 34.49 Mil. Grey Wolf Health's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current Shares Outstanding (EOP) is 34.49 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued. The current stock price of C$1.75 is trading 59.1% above its estimated GF Value™ of C$1.10. GuruFocus considers Grey Wolf Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • Shares Outstanding (EOP): 34.49 Mil
  • GF Value™: C$1.10 vs. price of C$1.75 (59.1% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grey Wolf Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
52GF Score

Get the complete analysis for TSXV:WOLF

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.75
Price
C$1.10
GF Value